Capital markets lawyers in Hong Kong are bullish about deal flow this year, as new listing rules are expected to attract more initial public offerings from tech and biotech companies.

The Hong Kong Stock Exchange announced on Tuesday that a set of new listing rules would take effect on April 30. The new regime will accept applicants with dual-class shares, a structure preferred by many startups and one that allows biotech companies with no revenue to list.